Risk stratification model for the pharmaceutical care of oncology patients with solid or hematologic neoplasms
CONCLUSION: This stratification model enables the identification of cancer patients requiring a higher level of pharmaceutical care and facilitates the adjustment of care capacity. Validation of the model in a representative population is necessary to establish its effectiveness.PMID:37884399 | DOI:10.1016/j.farma.2023.07.013
Source: Farmacia Hospitalaria - Category: Drugs & Pharmacology Authors: Beatriz Bernardez Irene Mangues-Bafalluy Virginia Mart ínez Callejo Juan Jos é Fernández Ávila Jose Antonio Marcos Rodr íguez Maria Angeles Parada Aradilla Mar ía José Martínez Bautista Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Hematology | Spain Health | Study | Workshops